688117 圣诺生物
已收盘 04-28 15:00:00
资讯
新帖
简况
圣诺生物04月28日获主力加仓2035.0万元
市场透视 · 11:26
圣诺生物04月28日获主力加仓2035.0万元
圣诺生物:一季报营收和净利润大增 AI赋能功效多肽研发开启护肤新纪元
证券市场周刊 · 04-26 13:36
圣诺生物:一季报营收和净利润大增 AI赋能功效多肽研发开启护肤新纪元
圣诺生物2025年一季报简析:营收净利润同比双双增长,应收账款上升
证券之星 · 04-25 22:18
圣诺生物2025年一季报简析:营收净利润同比双双增长,应收账款上升
圣诺生物:中泰证券、申万宏源等多家机构于4月25日调研我司
证券之星 · 04-25
圣诺生物:中泰证券、申万宏源等多家机构于4月25日调研我司
川股年报 | 圣诺生物:增收不增利 研发费用大幅增加
金融投资报 · 04-25
川股年报 | 圣诺生物:增收不增利 研发费用大幅增加
圣诺生物04月25日获主力加仓1725万元
市场透视 · 04-25
圣诺生物04月25日获主力加仓1725万元
圣诺生物2024年归母净利润降28.9%,经营现金流降70.2%
财中社 · 04-25
圣诺生物2024年归母净利润降28.9%,经营现金流降70.2%
研发创新与销售布局成效显著,圣诺生物2025年一季报业绩亮眼
全景网 · 04-25
研发创新与销售布局成效显著,圣诺生物2025年一季报业绩亮眼
圣诺生物涨5.58% 一季度业绩大增
智选洞察 · 04-25
圣诺生物涨5.58% 一季度业绩大增
圣诺生物:2025年第一季度净利润4711.97万元 同比暴涨186.06%
南方财经网 · 04-25
圣诺生物:2025年第一季度净利润4711.97万元 同比暴涨186.06%
图解圣诺生物年报:第四季度单季净利润同比减119.48%
证券之星 · 04-24
图解圣诺生物年报:第四季度单季净利润同比减119.48%
圣诺生物最新公告:一季度净利润同比增长186%
证券之星 · 04-24
圣诺生物最新公告:一季度净利润同比增长186%
圣诺生物:2024年净利润5002.37万元,同比下降28.88%
视频滚动新闻 · 04-24
圣诺生物:2024年净利润5002.37万元,同比下降28.88%
AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床
制药网 · 04-24
AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床
圣诺生物04月23日主力净流入201万元 散户资金抛售
市场透视 · 04-23
圣诺生物04月23日主力净流入201万元 散户资金抛售
化学制药行业盘中拉升,威尔药业涨9.09%
市场透视 · 04-22
化学制药行业盘中拉升,威尔药业涨9.09%
圣诺生物涨5% 生物医药融资创新
智选洞察 · 04-18
圣诺生物涨5% 生物医药融资创新
圣诺生物04月16日遭主力抛售576万元
市场透视 · 04-16
圣诺生物04月16日遭主力抛售576万元
圣诺生物大跌5% 近半年2家券商买入
智选洞察 · 04-16
圣诺生物大跌5% 近半年2家券商买入
加载更多
公司概况
公司名称:
成都圣诺生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-06-03
主营业务:
成都圣诺生物科技股份有限公司主营业务是多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。公司主要产品为制剂、原料药、药学研究服务、受托加工服务、定制生产。公司及子公司拥有发明专利32项、实用新型专利30项(其中2项同时取得国际专利)和大量非专利技术,先后获评国家级、省级科研和技术改造项目十余项。
发行价格:
17.90
{"stockData":{"symbol":"688117","market":"SH","secType":"STK","nameCN":"圣诺生物","latestPrice":30.2,"timestamp":1745823600000,"preClose":28.91,"halted":0,"volume":7788812,"delay":0,"changeRate":0.0446,"floatShares":112000000,"shares":112000000,"eps":0.7176,"marketStatus":"已收盘","change":1.29,"latestTime":"04-28 15:00:00","open":28.86,"high":30.77,"low":28.86,"amount":234000000,"amplitude":0.0661,"askPrice":30.2,"askSize":149,"bidPrice":30.16,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.7176,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745890200000},"marketStatusCode":5,"adr":0,"adjPreClose":28.91,"symbolType":"stock_kcb","openAndCloseTimeList":[[1745803800000,1745811000000],[1745816400000,1745823600000]],"highLimit":31.8,"lowLimit":26.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112418556,"isCdr":false,"pbRate":3.51,"roa":"--","peRate":42.084727,"roe":"5.0%","epsLYR":0.45,"committee":-0.221835,"marketValue":3395000000,"turnoverRate":0.0693,"status":0,"afterMarket":{"amount":0,"volume":0,"close":30.2,"buyVolume":0,"sellVolume":0,"time":1745825638029,"indexStatus":"已收盘 04-28 15:30:00","preClose":28.91},"floatMarketCap":3395000000},"requestUrl":"/m/hq/s/688117","defaultTab":"news","newsList":[{"id":"2530056464","title":"圣诺生物04月28日获主力加仓2035.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530056464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530056464?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:26","pubTimestamp":1745839587,"startTime":"0","endTime":"0","summary":"04月28日, 圣诺生物股价涨4.46%,报收30.20元,成交金额2.3亿元,换手率6.93%,振幅6.61%,量比1.21。圣诺生物今日主力资金净流入2035.0万元,连续4日净流入,上一交易日主力净流入1725.0万元。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为25.00%,平均涨幅为0.56%。该股近5个交易日上涨11.85%,主力资金累计净流入4798.0万元;近20日主力资金累计净流出1793.0万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428194802a46a648b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428194802a46a648b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2530212451","title":"圣诺生物:一季报营收和净利润大增 AI赋能功效多肽研发开启护肤新纪元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530212451","media":"证券市场周刊","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530212451?lang=zh_cn&edition=full","pubTime":"2025-04-26 21:36","pubTimestamp":1745674591,"startTime":"0","endTime":"0","summary":"2024年,公司实现营业收入45607.00万元,归母净利润5002.37万元。同日发布的一季报显示,受益于核心产品司美格鲁肽和替尔泊肽出品销售增加,圣诺生物2025年一季度营收和净利润大幅增长。圣诺生物作为功效多肽领域的领军企业,凭借 20 余年全产业链布局与技术积淀,充分受益于行业的快速发展。一季报营业收入和净利润的大幅增长即是公司全产业链布局优势的一个体现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426220440a6c95e80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426220440a6c95e80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117"],"gpt_icon":0},{"id":"2530682194","title":"圣诺生物2025年一季报简析:营收净利润同比双双增长,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2530682194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530682194?lang=zh_cn&edition=full","pubTime":"2025-04-26 06:18","pubTimestamp":1745619526,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期圣诺生物发布2025年一季报。截至本报告期末,公司营业总收入1.84亿元,同比上升77.15%,归母净利润4711.97万元,同比上升186.06%。本报告期圣诺生物应收账款上升,应收账款同比增幅达85.84%。2025年第一季度,实现营业收入18,433.70万元,同比增长77.15%;实现归属于母公司所有者的扣除非经常性损益的净利润4,794.31万元,同比增加213.63%;实现归属于母公司所有者的净利润4,711.97万元,同比增加186.06%,主要为司美格鲁肽和替尔泊肽销售增加,利润增加所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426062640a6c89dd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426062640a6c89dd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117"],"gpt_icon":0},{"id":"2530180984","title":"圣诺生物:中泰证券、申万宏源等多家机构于4月25日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2530180984","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530180984?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:32","pubTimestamp":1745584347,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年4月25日圣诺生物发布公告称中泰证券祝嘉琦 崔少煜、申万宏源张静含 余玉君、华福证券陈铁林 张绍辉、中信建投贺菊颖 袁清慧 王云鹏、国盛证券张金洋 胡偌碧 陈欣黎、国泰海通余文心 周航 陈铭、华安证券谭国超 杨馥瑗、兴业证券孙媛媛 黄翰漾 乔波耀、深圳盈润达王永泉于2025年4月25日调研我司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500034195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06806","BK1564","000166","BK0276","688117","600918","BK0028","BK0239","BK1147","BK0183","BK0188","BK0012"],"gpt_icon":0},{"id":"2530490973","title":"川股年报 | 圣诺生物:增收不增利 研发费用大幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2530490973","media":"金融投资报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530490973?lang=zh_cn&edition=full","pubTime":"2025-04-25 17:38","pubTimestamp":1745573927,"startTime":"0","endTime":"0","summary":"财报显示,2024年公司研发费用达4916.52万元,大幅增加69.26%。长期来看,随着人工智能的发展,AI 技术可大大缩短新药的研发时间并节省研发费用。据统计,传统模式下的药物研发光是临床前阶段可能就需要4—5年,而基于AI 和生物计算的新药研发管线平均1—2年就可以完成临床前药物研发,药物研发明显提速。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504251741239744d436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504251741239744d436&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2530089009","title":"圣诺生物04月25日获主力加仓1725万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530089009","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530089009?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:23","pubTimestamp":1745565801,"startTime":"0","endTime":"0","summary":"04月25日, 圣诺生物股价涨2.16%,报收28.91元,成交金额2.39亿元,换手率7.33%,振幅6.36%,量比1.30。圣诺生物今日主力资金净流入1725万元,连续3日净流入,上一交易日主力净流入1118万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为41.67%,平均涨幅为1.45%。该股近5个交易日上涨7.59%,主力资金累计净流入1815万元;近20日主力资金累计净流出3793万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425165045a4668d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425165045a4668d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2530945726","title":"圣诺生物2024年归母净利润降28.9%,经营现金流降70.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530945726","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530945726?lang=zh_cn&edition=full","pubTime":"2025-04-25 10:29","pubTimestamp":1745548192,"startTime":"0","endTime":"0","summary":"4月24日,圣诺生物公布2024年年报,公司营业收入为4.56亿元,同比上升4.8%;归母净利润为5002万元,同比下降28.9%;扣非归母净利润为4561万元,同比下降24.2%;经营现金流净额为2527万元,同比下降70.2%;EPS为0.445元。截至四季度末,公司总资产16.48亿元,较上年度末增长25.2%;归母净资产为9.18亿元,较上年度末增长4.4%。公司在2024年度的经营业务中,持续专注于多肽领域,积极推进原料药及制剂的扩产和改造,以提升CDMO服务能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042510303694e1d119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042510303694e1d119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","159399"],"gpt_icon":0},{"id":"2530596948","title":"研发创新与销售布局成效显著,圣诺生物2025年一季报业绩亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2530596948","media":"全景网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530596948?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:38","pubTimestamp":1745545080,"startTime":"0","endTime":"0","summary":"2025年一季度,公司业绩表现亮眼,实现营业收入1.84亿元,同比增长77.15%,实现归母净利润4711.97万元,同比大增186.06%。研发创新与全球市场布局,奠定增长基石2024年,公司研发投入创历史新高,创新成果丰硕。圣诺生物凭借领先的合成技术、稳定的产品质量及快速响应能力,抢占高端原料药市场份额,一季度销售收入同比大幅提升,成为业绩增长的关键动力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042509401594e1bf3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042509401594e1bf3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2530948591","title":"圣诺生物涨5.58% 一季度业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2530948591","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530948591?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:30","pubTimestamp":1745544601,"startTime":"0","endTime":"0","summary":"04月25日,圣诺生物股价大幅上涨,截至09点30分,圣诺生物上涨5.58%,报29.88元/股,成交1172万元,换手率0.35%,振幅0.49%。消息解读圣诺生物发布2025年第一季度报告,报告期实现营业收入1.84亿元,同比增长77.15%;归属上市公司股东的净利润4711.97万元,同比增长186.06%;扣除非经常性损益后的归属于上市公司股东的净利润4794.31万元,同比增长213.63%;基本每股收益0.42元。资金动向截止发稿,圣诺生物获得主力净流入274万元,其中超大单流入142万元,大单流入131万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425093057974449b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425093057974449b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2530911125","title":"圣诺生物:2025年第一季度净利润4711.97万元 同比暴涨186.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530911125","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530911125?lang=zh_cn&edition=full","pubTime":"2025-04-25 08:31","pubTimestamp":1745541085,"startTime":"0","endTime":"0","summary":"南财智讯4月25日电,圣诺生物发布2025年第一季度报告,报告期实现营业收入1.84亿元,同比增长77.15%;归属上市公司股东的净利润4711.97万元,同比增长186.06%;扣除非经常性损益后的归属于上市公司股东的净利润4794.31万元,同比增长213.63%;基本每股收益0.42元。文章来源:南方财经网原标题:圣诺生物:2025年第一季度净利润4711.97万元 同比暴涨186.06%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425084913a4661002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425084913a4661002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117"],"gpt_icon":0},{"id":"2530963353","title":"图解圣诺生物年报:第四季度单季净利润同比减119.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530963353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530963353?lang=zh_cn&edition=full","pubTime":"2025-04-25 01:33","pubTimestamp":1745516013,"startTime":"0","endTime":"0","summary":"证券之星消息,圣诺生物2024年年报显示,公司主营收入4.56亿元,同比上升4.84%;归母净利润5002.37万元,同比下降28.88%;扣非净利润4561.24万元,同比下降24.24%;其中2024年第四季度,公司单季度主营收入1.18亿元,同比下降17.78%;单季度归母净利润-692.29万元,同比下降119.48%;单季度扣非净利润-804.31万元,同比下降121.83%;负债率44.27%,投资收益171.57万元,财务费用920.21万元,毛利率57.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500000923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117"],"gpt_icon":0},{"id":"2529451958","title":"圣诺生物最新公告:一季度净利润同比增长186%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529451958","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529451958?lang=zh_cn&edition=full","pubTime":"2025-04-24 22:59","pubTimestamp":1745506783,"startTime":"0","endTime":"0","summary":"圣诺生物(688117.SH)发布2025年第一季度报告,实现营业收入1.84亿元,同比增长77.15%;归属于上市公司股东的净利润4711.97万元,同比增长186.06%。净利润增长系司美格鲁肽和替尔泊肽销售增加所致。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400041175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117"],"gpt_icon":0},{"id":"2529953583","title":"圣诺生物:2024年净利润5002.37万元,同比下降28.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529953583","media":"视频滚动新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529953583?lang=zh_cn&edition=full","pubTime":"2025-04-24 22:55","pubTimestamp":1745506500,"startTime":"0","endTime":"0","summary":"圣诺生物公告,2024年营业收入为4.56亿元,同比增长4.84%。归属于上市公司股东的净利润5002.37万元,同比下降28.88%。公司拟向全体股东每10股分派现金红利1.4元(含税),合计拟派发现金红利1573.86万元(含税),占公司2024年度归属于母公司股东净利润的比例为31.46%。同时以资本公积金转增股本方式向全体股东每10股转增4股,合计转增4496.74万股,转增后公司总股本变更为1.57亿股。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:小浪快报","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2025-04-24/doc-ineuhuek1916769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688117"],"gpt_icon":0},{"id":"2529793817","title":"AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2529793817","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529793817?lang=zh_cn&edition=full","pubTime":"2025-04-24 14:57","pubTimestamp":1745477831,"startTime":"0","endTime":"0","summary":"自 AI 技术开始应用于药物研发以来,AI 驱动的药物管线数量呈现出爆发式增长。如今,全球范围内已有 102 个 AI 驱动的药物管线获批临床试验,其中56个处于Ⅰ期、41个处于Ⅱ期、5个处于Ⅲ期,涵盖了多种疾病领域,包括肿瘤、神经系统疾病、心血管疾病等。一些用于治疗心律失常、心力衰竭等心血管疾病的 AI 驱动药物管线,正在临床试验中接受进一步验证,有望为心血管疾病患者提供更有效的治疗方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042414581494e09c56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042414581494e09c56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","603367","605507","600216","603669","605116","688799","600267","600521","603676","BK0239","600851","600488","600420","688076","688566","688578","600062","BK0168","601089","BK0046","BK0188","600789","600812","603351","600380","603538","688658"],"gpt_icon":0},{"id":"2529995571","title":"圣诺生物04月23日主力净流入201万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529995571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529995571?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:21","pubTimestamp":1745392873,"startTime":"0","endTime":"0","summary":"04月23日, 圣诺生物股价涨2.15%,报收28.05元,成交金额1.74亿元,换手率5.54%,振幅4.01%,量比0.98。圣诺生物今日主力资金净流入201万元,上一交易日主力净流出282万元。该股近5个交易日上涨4.16%,主力资金累计净流出1178万元;近20日主力资金累计净流出6529万元,其中净流出天数为13日。|04月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|健尔康|8.43%|#|新天地|7.95%|#|利安科技|7.56%|#|...|...|#1223|圣诺生物|0.06%|圣诺生物所在的化学制药行业,今日主力净流出1.78亿元,行业排名28/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423162229a6c4e241&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423162229a6c4e241&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2529588153","title":"化学制药行业盘中拉升,威尔药业涨9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529588153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529588153?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:44","pubTimestamp":1745286262,"startTime":"0","endTime":"0","summary":"04月22日,化学制药行业盘中拉升,截至09点44分,化学制药行业整体指数上涨1.01%,报10985.070点。从个股上来看,该行业的成分股中,威尔药业涨9.09%,富祥药业、东诚药业等4只股涨幅超过5%。从资金上来看,截止发稿,化学制药行业主力净流入为-1.59亿,其中东诚药业受到资金热捧,主力净流入2513.18万;拉长时间线来看,该板块近20日主力资金净流入-68.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0239","688117","600789","BK0028","603538","603351","600196","688513","688578","688356","600613","688076","600521","688166","600267","688505","600276","688566","600488","603707","688189","688799","688690","BK0060","600216","600812","688091","600624","688506","603676","600420","605116","603811","603229","605177","605507","600513","688247","BK0275","600380"],"gpt_icon":0},{"id":"2528707685","title":"圣诺生物涨5% 生物医药融资创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2528707685","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528707685?lang=zh_cn&edition=full","pubTime":"2025-04-18 09:33","pubTimestamp":1744940020,"startTime":"0","endTime":"0","summary":"04月18日,圣诺生物股价大幅上涨,截至09点33分,圣诺生物上涨5.04%,报27.70元/股,成交6129万元,换手率1.99%,振幅2.31%。资金动向截止发稿,圣诺生物获得主力净流入845万元,其中超大单流入934万元,大单流出88万元。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418093447a45d401b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418093447a45d401b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399441","688117","161726","BK0239"],"gpt_icon":0},{"id":"2527634602","title":"圣诺生物04月16日遭主力抛售576万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527634602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527634602?lang=zh_cn&edition=full","pubTime":"2025-04-16 15:21","pubTimestamp":1744788090,"startTime":"0","endTime":"0","summary":"04月16日, 圣诺生物股价跌3.13%,报收26.93元,成交金额1.56亿元,换手率5.17%,振幅5.36%,量比0.61。圣诺生物今日主力资金净流出576万元,连续3日净流出,上一交易日主力净流出2789万元。该股近5个交易日下跌1.17%,主力资金累计净流出5233万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出6198万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416165834a6bc56e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416165834a6bc56e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2527128238","title":"圣诺生物大跌5% 近半年2家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527128238","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527128238?lang=zh_cn&edition=full","pubTime":"2025-04-16 11:27","pubTimestamp":1744774077,"startTime":"0","endTime":"0","summary":"04月16日,圣诺生物股价大幅下跌,截至11点27分,圣诺生物下跌5.11%,报26.38元/股,成交9548万元,换手率3.15%。此外,数据统计显示,近半年内2家券商给予买入建议。资金动向截止发稿,圣诺生物获得主力净流出786万元,其中超大单流出726万元,大单流出59万元。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504161128269739604c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504161128269739604c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745858902013,"stockEarnings":[{"period":"1week","weight":0.1185},{"period":"1month","weight":0.2367},{"period":"3month","weight":0.2276},{"period":"6month","weight":0.0168},{"period":"1year","weight":0.0664},{"period":"ytd","weight":0.1765}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":-0.0188},{"period":"3month","weight":0.0116},{"period":"6month","weight":0.0068},{"period":"1year","weight":0.0647},{"period":"ytd","weight":-0.0189}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都圣诺生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7374人(较上一季度增加16.22%)","perCapita":"15245股","listingDate":"2021-06-03","address":"四川省成都市大邑县晋原镇工业大道一段(工业集中发展区内)","registeredCapital":"11241万元","survey":" 成都圣诺生物科技股份有限公司主营业务是多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。公司主要产品为制剂、原料药、药学研究服务、受托加工服务、定制生产。公司及子公司拥有发明专利32项、实用新型专利30项(其中2项同时取得国际专利)和大量非专利技术,先后获评国家级、省级科研和技术改造项目十余项。","listedPrice":17.9},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺生物,688117,圣诺生物股票,圣诺生物股票老虎,圣诺生物股票老虎国际,圣诺生物行情,圣诺生物股票行情,圣诺生物股价,圣诺生物股市,圣诺生物股票价格,圣诺生物股票交易,圣诺生物股票购买,圣诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}